IVPost
Rury R. Holman, FMedSci, Receives American Diabetes Association’s Outstanding Achievement in Clinical Diabetes Research Award
- Details
- Written by Michelle Kirkwood
- Category: Health News
The American Diabetes Association® (ADA) will present the 2018 Outstanding Achievement in Clinical Diabetes Research Award to Rury R. Holman, FMedSci. This award recognizes exceptional contributions in patient-oriented or clinical outcomes research that have had a significant impact on diabetes prevention and treatment. Dr. Holman will be recognized with this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando.
Mark A. Atkinson, PhD, Named American Diabetes Association’s ® 2018 Albert Renold Award Recipient
- Details
- Written by Michelle Kirkwood
- Category: Latest News
Mark A. Atkinson, PhD, has been selected to receive the American Diabetes Association’s® (ADA’s) 2018 Albert Renold Award. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Atkinson will be recognized with this honor during the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando.
Three CDC scientists named as 2018 Service to America Medal Finalists
- Details
- Written by IVPost
- Category: Latest News
The Partnership for Public Service has announced its nominees for the 2018 Service to America Medals, known as the “Sammies.” CDC has three finalists for these prestigious public health awards that recognize the talents and achievements of federal employees. The CDC finalists are Drs. Marshalyn Yeargin-Allsopp (developmental disabilities), Margaret (Peggy) Honein (Zika), and John Sammarco (mine safety).
Study upends conventional view of opioid mechanism of action
- Details
- Written by NIDA
- Category: Medical News
A new discovery shows that opioids used to treat pain, such as morphine and oxycodone, produce their effects by binding to receptors inside neurons, contrary to conventional wisdom that they acted only on the same surface receptors as endogenous opioids, which are produced naturally in the brain. However, when researchers funded by the National Institute on Drug Abuse (NIDA) used a novel molecular probe to test that common assumption, they discovered that medically used opioids also bind to receptors that are not a target for the naturally occurring opioids. NIDA is part of the National Institutes of Health.
Scientists uncover brain circuits behind putting up a fight or freezing in place
- Details
- Written by Barbara McMakin
- Category: Latest News
In a study of mice, National Institutes of Health-funded researchers describe a new circuit involved in fine-tuning the brain’s decision either to hide or confront threats. The study, published in Nature, was partially funded by the NIH’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
More than one day of early-pregnancy bleeding linked to lower birthweight
- Details
- Written by NIH
- Category: Health News
Women who experience vaginal bleeding for more than one day during the first trimester of pregnancy may be more likely to have a smaller baby, compared to women who do not experience bleeding in the first trimester, suggest researchers at the National Institutes of Health. On average, full-term babies born to women with more than one day of bleeding in the first trimester were about 3 ounces lighter than those born to women with no bleeding during this time. Additionally, infants born to women with more than a day of first trimester bleeding were roughly twice as likely to be small for gestational age, a category that includes infants who are healthy but small, as well as those whose growth has been restricted because of insufficient nutrition or oxygen or other causes.
Page 10 of 50